{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:57:19Z","timestamp":1762145839189,"version":"3.43.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>Adults and children with sickle cell disease (SCD) are predominantly African American, with pain-related health disparities. We examined opioid prescription fill patterns in adults and children with SCD and compared factors associated with fills in North Carolina Medicaid enrollees. Our retrospective cohort study included 955 enrollees diagnosed with SCD having at least one opioid fill. Associations were measured between two cohorts (12 and 24\u2002mo of continuous enrollment) for the following characteristics: sex, age, enrollee residence, hydroxyurea adherence, comanagement, enrollment in Community Care North Carolina, prescription for short versus short and long-acting opioids, and emergency department reliance. The majority of individuals did not have an opioid claim over a 12 or 24-month period. Claims increased at ages 10 to 17, peaking at ages 18 to 30. The increased number of claims was associated with the following factors: increasing age, male, short versus long-acting opioids, and Medicaid enrollment for 24 versus 12 months. Community Care North Carolina enrollees in the 12-month cohort had higher opioid days of supply per month; the inverse was true of the 24-month cohort.<\/jats:p>","DOI":"10.1097\/mph.0000000000002852","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T14:00:10Z","timestamp":1711720810000},"page":"181-187","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Opioid Use Among Children and Adults With Sickle Cell Disease in North Carolina Medicaid Enrollees in the Era of Opioid Harm Reduction"],"prefix":"10.1097","volume":"46","author":[{"given":"Nancy","family":"Crego","sequence":"first","affiliation":[{"name":"School of Nursing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Douglas","sequence":"additional","affiliation":[{"name":"School of Nursing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Bonnabeau","sequence":"additional","affiliation":[{"name":"School of Nursing"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kern","family":"Eason","sequence":"additional","affiliation":[{"name":"School of Medicine, Duke University, Durham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Earls","sequence":"additional","affiliation":[{"name":"Community Care of North Carolina, Cary, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Tanabe","sequence":"additional","affiliation":[{"name":"School of Nursing"},{"name":"School of Medicine, Duke University, Durham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmish","family":"Shah","sequence":"additional","affiliation":[{"name":"School of Medicine, Duke University, Durham"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,3,28]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.21570","article-title":"The number of people with sickle cell disease in the United States: national and state estimates","volume":"85","author":"Brousseau","year":"2009","journal-title":"Am J Hematol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"e20160331","DOI":"10.1542\/peds.2016-0331","article-title":"Pediatric chronic pain: biopsychosocial assessment and formulation","volume":"138","author":"Liossi","year":"2016","journal-title":"Pediatrics"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/AJP.0000000000000403","article-title":"Widespread pain among youth with sickle cell disease hospitalized with vasoocclusive pain: a different clinical phenotype?","volume":"33","author":"Zempsky","year":"2017","journal-title":"Clin J Pain"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"E345","DOI":"10.1002\/ajh.25233","article-title":"Opioid utilization patterns in United States individuals with sickle cell disease","volume":"93","author":"Ballas","year":"2018","journal-title":"Am J Hematol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jpain.2013.03.007","article-title":"Validation of the sickle cell disease pain burden interview-youth","volume":"14","author":"Zempsky","year":"2013","journal-title":"J Pain"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/ajh.25168","article-title":"Predictors of acute care utilization and acute pain treatment outcomes in adults with sickle cell disease: The role of non-hematologic characteristics and baseline chronic opioid dose","volume":"93","author":"Carroll","year":"2018","journal-title":"Am J Hematol"},{"key":"R8-20250804","first-page":"420","article-title":"Parental substance abuse, reports of chronic pain and coping in adult patients with sickle cell disease","volume":"98","author":"Edwards","year":"2006","journal-title":"J Natl Med Assoc"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"e180217","DOI":"10.1001\/jamanetworkopen.2018.0217","article-title":"The burden of opioid-related mortality in the United States","volume":"1","author":"Gomes","year":"2018","journal-title":"JAMA Network Open"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/ajh.24498","article-title":"Patterns of opioid use in sickle cell disease","volume":"91","author":"Han","year":"2016","journal-title":"Am J Hematol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00277-021-04502-2","article-title":"Opioids are not a major cause of death of patients with sickle cell disease","volume":"100","author":"Ballas","year":"2021","journal-title":"Annals of hematology"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3122\/jabfm.2020.01.190143","article-title":"Sickle-cell disease co-management, health care utilization, and hydroxyurea use","volume":"33","author":"Crego","year":"2020","journal-title":"J Am Board Fam Med"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/pop.2013.0055","article-title":"Health care savings with the patient-centered medical home: community Care of North Carolina\u2019s experience","volume":"17","author":"Fillmore","year":"2014","journal-title":"Popul Health Manag"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ajh.21807","article-title":"The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database","volume":"85","author":"Lanzkron","year":"2010","journal-title":"Am J Hematol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jemermed.2014.12.080","article-title":"Age-related emergency department reliance in patients with sickle cell disease","volume":"49","author":"Blinder","year":"2015","journal-title":"J Emerg Med"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1542\/peds.2009-0960","article-title":"Emergency department reliance: a discriminatory measure of frequent emergency department users","volume":"125","author":"Kroner","year":"2010","journal-title":"Pediatrics"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1542\/peds.2014-0177","article-title":"Medication adherence among pediatric patients with sickle cell disease: a systematic review","volume":"134","author":"Walsh","year":"2014","journal-title":"Pediatrics"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ajh.21968","article-title":"Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease","volume":"86","author":"Candrilli","year":"2011","journal-title":"Am J Hematol"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1517\/14740338.2015.1088827","article-title":"Hydroxyurea therapy for sickle cell anemia","volume":"14","author":"McGann","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1056\/NEJMp2022125","article-title":"When actions speak louder than words\u2014racism and sickle cell disease","volume":"383","author":"Power-Hays","year":"2020","journal-title":"N Engl J Med"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s11606-022-07786-w","article-title":"Prevalence of substance use disorders in sickle cell disease compared to other chronic conditions: a population-based study of black American adults","volume":"38","author":"Jonassaint","year":"2023","journal-title":"J Gen Intern Med"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1182\/blood-2022-163718","article-title":"Self-efficacy and stigma in adults with sickle cell disease: an import study analysis","volume":"140","author":"Guarino","year":"2022","journal-title":"Blood"},{"key":"R27-20250804","first-page":"1050","article-title":"Health-related stigma in young adults","volume":"102","author":"Jenerette","year":"2010","journal-title":"J Natl Med Assoc"},{"key":"R28-20250804","first-page":"23","article-title":"Stigma in adults with sickle cell disease and family members: Scale development and pilot study in the USA and Nigeria","volume":"9","author":"Leger","year":"2018","journal-title":"Int J Africa Nurs Sci"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0193945913512724","article-title":"An intervention to decrease stigma in young adults with sickle cell disease","volume":"36","author":"Jenerette","year":"2014","journal-title":"West J Nurs Res"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"e0257796","DOI":"10.1371\/journal.pone.0257796","article-title":"Profile of Medicaid enrollees with sickle cell disease: a high need, high cost population","volume":"16","author":"Grady","year":"2021","journal-title":"PLoS One"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"R32-20250804","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/j.pain.0000000000000824","article-title":"Sickle cell disease: a natural model of acute and chronic pain","volume":"158","author":"Brandow","year":"2017","journal-title":"Pain"},{"key":"R33-20250804","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jama.2010.378","article-title":"Acute care utilization and rehospitalizations for sickle cell disease","volume":"303","author":"Brousseau","year":"2010","journal-title":"J Am Med Assoc"},{"key":"R34-20250804","doi-asserted-by":"crossref","first-page":"4070547","DOI":"10.1155\/2017\/4070547","article-title":"Comorbidity, pain, utilization, and psychosocial outcomes in older versus younger sickle cell adults: the PiSCES project","volume":"2017","author":"McClish","year":"2017","journal-title":"Biomed Res Int"},{"key":"R35-20250804","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/CNQ.0000000000000350","article-title":"Patient perspectives of sickle cell management in the emergency department","volume":"44","author":"Crego","year":"2021","journal-title":"Crit Care Nurs Q"},{"key":"R36-20250804","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pmn.2012.10.007","article-title":"Care seeking for pain in young adults with sickle cell disease","volume":"15","author":"Jenerette","year":"2014","journal-title":"Pain Manag Nurs"},{"key":"R37-20250804","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/pbc.22605","article-title":"Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysis","volume":"55","author":"Patel","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R38-20250804","first-page":"1412","article-title":"The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease","volume":"26","author":"Kang","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"key":"R39-20250804","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/pbc.24870","article-title":"Identification of risk factors for an unsuccessful transition from pediatric to adult sickle cell disease care","volume":"61","author":"Andemariam","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R40-20250804","doi-asserted-by":"crossref","first-page":"e27463","DOI":"10.1002\/pbc.27463","article-title":"Transition to adult care in sickle cell disease: a longitudinal study of clinical characteristics and disease severity","volume":"66","author":"Kayle","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R41-20250804","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"key":"R42-20250804","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jemermed.2022.01.002","article-title":"Frequency of opioid prescription filling after discharge from the pediatric emergency department","volume":"62","author":"Hrdy","year":"2022","journal-title":"J Emerg Med"},{"key":"R43-20250804","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/AJP.0000000000000289","article-title":"Psychosocial and functional outcomes in youth with chronic sickle cell pain","volume":"32","author":"Sil","year":"2016","journal-title":"Clin J Pain"},{"key":"R44-20250804","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jpain.2016.12.016","article-title":"AAPT diagnostic criteria for chronic sickle cell disease pain","volume":"18","author":"Dampier","year":"2017","journal-title":"J Pain"},{"key":"R45-20250804","first-page":"76","article-title":"Understanding the self-management practices of young adults with sickle cell disease","volume":"2017","author":"Matthie","year":"2017","journal-title":"J Sickle Cell Dis Hemoglobinopathies"},{"key":"R46-20250804","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/j.pain.0000000000002297","article-title":"Efficacy and safety of pharmacological, physical, and psychological interventions for the management of chronic pain in children: a WHO systematic review and meta-analysis","volume":"163","author":"Fisher","year":"2022","journal-title":"Pain"},{"key":"R47-20250804","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/hex.13692","article-title":"Self-management interventions for children and young people with sickle cell disease: a systematic review","volume":"26","author":"Poku","year":"2023","journal-title":"Health Expect"},{"key":"R48-20250804","first-page":"251","article-title":"Dissemination and adoption of guidelines: the experience of community care of North Carolina","volume":"76","author":"Tilson","year":"2015","journal-title":"N C Med J"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:00:21Z","timestamp":1754337621000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,28]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002852","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2024,3,28]]},"assertion":[{"value":"2023-07-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}